Short answer
CareDx, Inc. (CDNA) filed an 8-K current report with the SEC on June 15, 2026 reporting Item 5.02 (Departure/Election of Directors or Officers), Item 5.07 (Submission of Matters to a Vote of Security Holders). Stockholders approved an amendment to CareDx’s 2024 Equity Incentive Plan.
CareDx, Inc. 8-K event analysis
AI summary of each reported item and its exhibits
Item 5.02 · Departure/Election of Directors or Officers
- Stockholders approved an amendment to CareDx’s 2024 Equity Incentive Plan
- Equity-plan change may affect future share issuance and potential dilution
- Filing references Annual Meeting approval on June 11, 2026
Item 5.07 · Submission of Matters to a Vote of Security Holders
- 48,142,732 shares represented at meeting, approximately 93% of voting power, supporting strong shareholder participation
- All five director nominees elected for one-year terms through 2027, preserving board continuity
- Deloitte & Touche ratified with 48,012,497 votes, providing shareholder approval of 2026 audit oversight
- Executive compensation approved advisory basis with 39,387,247 votes; annual say-on-pay votes selected
- 2024 Equity Incentive Plan amendment approved 27,575,633 to 13,702,645, increasing available equity compensation capacity
Generated from the filing text and exhibits; verify against the original. What 8-K item codes mean
Other CareDx, Inc. 8-K filings
Get the next CDNA 8-K as it lands
Follow CDNA for push alerts, or ask the research agent what this filing means.